|
Pascual-Figal DA, Bayes-Genis A, Asensio-Lopez MC, Hernandez-Vicente A, Garrido-Bravo I, Pastor-Perez F, Diez J, Ibanez B, Lax A. The Interleukin-1 Axis and Risk of Death in Patients With Acutely Decompensated Heart Failure. J Am Coll Cardiol. 2019 Mar 12;73(9):1016-1025. doi: 10.1016/j.jacc.2018.11.054. PubMed PMID: 30846095.
AÑO: 2019; IF: 20.589
|
30846095
|
Canepa M, Fonseca C, Chioncel O, Laroche C, Crespo-Leiro MG, Coats AJS, Mebazaa A, Piepoli MF, Tavazzi L, Maggioni AP; ESC HF Long Term Registry Investigators. Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry. JACC Heart Fail. 2018 Jun;6(6):452-462. doi: 10.1016/j.jchf.2018.02.001. PubMed PMID: 29852929.
AÑO: 2018; IF: 8.91
|
|
Maurer MS, Schwartz JH, Gundapaneni B, Elliott PM, Merlini G, Waddington-Cruz M, Kristen AV, Grogan M, Witteles R, Damy T, Drachman BM, Shah SJ, Hanna M, Judge DP, Barsdorf AI, Huber P, Patterson TA, Riley S, Schumacher J, Stewart M, Sultan MB, Rapezzi C; ATTR-ACT Study Investigators. Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy. N Engl J Med. 2018 Sep 13;379(11):1007-1016. doi: 10.1056/NEJMoa1805689. Epub 2018 Aug 27. PubMed PMID: 30145929.
AÑO: 2018; IF: 70.67
|
|
Sabater-Molina M, Navarro M, García-Molina Sáez E, Garrido I, Pascual-Figal D, González Carrillo J, Gimeno Blanes JR. Mutation in JPH2 cause dilated cardiomyopathy. Clin Genet. 2016 Nov;90(5):468-469. doi: 10.1111/cge.12825. Epub 2016 Jul 29. PubMed PMID: 27471098.
AÑO: 2016; IF: 3.326
|
|
Lax A, Sanchez-Mas J, Asensio-Lopez MC, Fernandez-Del Palacio MJ, Caballero L, Garrido IP, Pastor-Perez FJ, Januzzi JL, Pascual-Figal DA. Mineralocorticoid receptor antagonists modulate galectin-3 and interleukin-33/ST2 signaling in left ventricular systolic dysfunction after acute myocardial infarction. JACC Heart Fail. 2015 Jan;3(1):50-8. doi: 10.1016/j.jchf.2014.07.015. PubMed PMID: 25458175.
AÑO: 2015; IF: 7.218
|